METex14 Mutations
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU) (NCT05154344) | Intergroupe Francophone de Cancerologie Thoracique | 2021-11-29 |
Track METex14 Mutations automatically
Every clearance here is in the API, with alerts when new ones post.